Insider Transactions in Q3 2022 at Intercept Pharmaceuticals, Inc. (ICPT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2022
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
908
-1.54%
|
$12,712
$14.85 P/Share
|
|
Sep 14
2022
|
M Michelle Berrey President, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-1.72%
|
$21,182
$17.14 P/Share
|
|
Sep 01
2022
|
Rocco Venezia Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-2.56%
|
$7,722
$18.06 P/Share
|
|
Sep 01
2022
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-1.77%
|
$10,746
$18.06 P/Share
|
|
Aug 15
2022
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-0.37%
|
$2,232
$18.19 P/Share
|
|
Aug 01
2022
|
Jared Freedberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
771
-1.55%
|
$9,252
$12.21 P/Share
|
|
Jul 11
2022
|
Bryan Ball Chief Qual. Officer & SVP Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
436
-1.7%
|
$6,104
$14.57 P/Share
|